MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
Breast Cancer · Gastrointestinal Cancer · Lung Cancer (Diagnosis) · Prostate Cancer (Diagnosis) · Head and Neck Cancer (H&N) · Bladder Cancer
De qué trata este estudio
El registro no identifica actualmente este estudio como reclutando. Consulta su estado antes de planificar una evaluación.
- Tipo de estudio
- De intervención
- Fase
- No aplica
- Rango de edad
- 18 años - 70 años
- Sexo admitido
- Todos los sexos
- Voluntarios sanos
- Aceptados
- Participantes
- 100 Estimado
Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.
Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.
Acerca de la investigación
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effects
Leer la descripción completa
This study focuses on testing the effectiveness of MyPatientPal+, the combination of MyPatientPal smartphone app and a newly developed provider dashboard, on patient quality of life, adherence to medications, and severity of side effects on patients who are on cancer treatment. Participants will use the MyPatientPal+ smartphone daily to complete daily patient reported outcome questions (PROs) for 8 weeks. Providers will enter information as desired and not on a set schedule.
¿Quién podría participar?
La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.
Inclusion Criteria:
Patients-
- 18-70 Years of age
- have a diagnosis of breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer
- about to initiate chemotherapy using one of the regimens listed in the protocol
- be able to speak, read, and write English
- willing and able to provide consent
- have access to a stable internet connection
Providers:
- being a practicing oncologist
- treating patients at Karmanos Cancer Institute (KCI) who are enrolled and consent to using the MyPatientPal+ smartphone app
- provide consent for the study
Exclusion Criteria:
Patients-
- cognitive or perceptual disturbances that prevent completing study measures Provider-
- None
Tratamiento, grupos y participación
El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.
- Asignación
- No aplica
- Enmascaramiento
- Sin enmascaramiento
MyPatientPal+ Smartphone Application
Participants report daily side effects and medications. Application includes a provider dashboard to track patients side effects and medications.
Behavioral: MyPatientPal+
MyPatientPal+ BEHAVIORAL
The intervention will consist of patients using the MyPatientPal+ application to complete daily patient reported outcome questions (PROs) of: (a) patient quality of life, (b) medication use, and (c) severity of side effects, and their providers who will elect to receive a weekly summary of patient's daily PRO reports electronically (e.g., email) or through the dashboard.
Qué evalúan los investigadores
Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.
Medidas principales
Single-item daily Quality of Life (Patient)
Plazo: Daily for 8 weeks
Patients will report their daily quality of life daily using MyPatientPal smartphone app. The question: "How was your quality of life today?" has a 7-point scale ranging from 1=very poor to 7=excellent.
Medidas secundarias
Adherence to medications (patient)
Plazo: Daily for 8 weeks
Patients will report any medications they are taking related to their treatment. Each report will consist of them answering a forced-choice question about whether each of their prescribed medications was taken (0=yes, 1=no). The investigators will compare the ratio of total days of adherence/total number of days per medication between the weekly and daily reporting phases. There will be no set number of medications that will be assessed given that the app will be set up to record only those medications the patient is prescribed, but on average, most patients will report on 3 medications. Examples may include Xeloda, Ibrance, Femara, Tamoxifen, Remeron, Reglan, or Compazine.
Severity of side effects (patient)
Plazo: Daily for 8 weeks
The severity of treatment-related symptoms will be examined as the primary outcome. Patients will report the severity of symptoms selected to match their current or expected side using the National Cancer Institute (NCI) CTCAE (Common Terminology Criteria for Adverse Events). Examples include diarrhea, constipation, vomiting, fever, and fatigue. Patients will be asked to mark the severity of each symptom using a 5-point rating scale (from 0=none to 4=very severe).
Patient quality of life
Plazo: Weekly for 8 weeks
Patients will report their quality of life using the FACT-G (Functional Assessment of Cancer Therapy), a widely accepted measure of general functioning and quality of life among cancer patients. The measure has a total score and also four subscales assessing social, functional, emotional, and physical domains.
Revisa las tablas completas y sus limitaciones en el registro oficial.
Abrir resultados oficiales ↗Centros de investigación (1)
El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.
1 centros
Karmanos Cancer InstituteDetroit, Michigan, United StatesEstado desconocido
Equipo y fechas
- Patrocinador principal
- Barbara Ann Karmanos Cancer Institute
- Inicio del estudio
- 2026-11 Estimado
- Finalización primaria
- 30 nov 2028 Estimado
- Finalización del estudio
- 30 nov 2028 Estimado
- Primera publicación
- 10 nov 2026 Real
- Última actualización
- 10 nov 2026 Real
Contactos oficiales del estudio
Título oficial del estudio
MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment
Consulta a Wellness Clinical Research
Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.
Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.
Consultado: 12 nov 2026 · Última actualización del registro: 10 nov 2026